EP3858349A1 — Nitrogen-containing spiro-ring compound and medicinal use of same
Assigned to Japan Tobacco Inc · Expires 2021-08-04 · 5y expired
What this patent protects
A compound of the following general formula [I]:wherein each symbol has the same meaning as defined herein, or a pharmaceutically acceptable salt thereof, or a solvate thereof, and a pharmaceutical use of the same in treating organ transplant rejection, graft versus host reaction…
USPTO Abstract
A compound of the following general formula [I]:wherein each symbol has the same meaning as defined herein, or a pharmaceutically acceptable salt thereof, or a solvate thereof, and a pharmaceutical use of the same in treating organ transplant rejection, graft versus host reaction after transplantation, autoimmune disease, allergic disease and chronic myeloproliferative disease.
Drugs covered by this patent
- Corectim (DELGOCITINIB) · Japan Tobacco
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.